This report aims to provide a comprehensive presentation of the global market for Nausea And Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nausea And Vomiting Treatment.
The Nausea And Vomiting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nausea And Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Product Type Insights
Global markets are presented by Nausea And Vomiting Treatment type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Nausea And Vomiting Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Nausea And Vomiting Treatment segment by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nausea And Vomiting Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nausea And Vomiting Treatment market.
Nausea And Vomiting Treatment Segment by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nausea And Vomiting Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea And Vomiting Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nausea And Vomiting Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nausea And Vomiting Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea And Vomiting Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nausea And Vomiting Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Nausea And Vomiting Treatment by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
2.3 Nausea And Vomiting Treatment by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 CINV
2.3.3 PONV
2.3.4 Motion Sickness
2.3.5 Pregnancy
2.3.6 Others
2.4 Assumptions and Limitations
3 Nausea And Vomiting Treatment Breakdown Data by Type
3.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2019-2024)
3.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030)
4 Nausea And Vomiting Treatment Breakdown Data by Application
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2019-2024)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Nausea And Vomiting Treatment Market Perspective (2019-2030)
5.2 Global Nausea And Vomiting Treatment Growth Trends by Region
5.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2019-2024)
5.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030)
5.3 Nausea And Vomiting Treatment Market Dynamics
5.3.1 Nausea And Vomiting Treatment Industry Trends
5.3.2 Nausea And Vomiting Treatment Market Drivers
5.3.3 Nausea And Vomiting Treatment Market Challenges
5.3.4 Nausea And Vomiting Treatment Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Nausea And Vomiting Treatment Players by Revenue
6.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2019-2024)
6.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2024)
6.2 Global Nausea And Vomiting Treatment Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Nausea And Vomiting Treatment Head office and Area Served
6.4 Global Nausea And Vomiting Treatment Players, Product Type & Application
6.5 Global Nausea And Vomiting Treatment Players, Date of Enter into This Industry
6.6 Global Nausea And Vomiting Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Nausea And Vomiting Treatment Market Size (2019-2030)
7.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
7.4 North America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Nausea And Vomiting Treatment Market Size (2019-2030)
8.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024)
8.4 Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2019-2030)
9.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2019-2024)
9.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Nausea And Vomiting Treatment Market Size (2019-2030)
10.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
10.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2019-2030)
11.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2019-2024)
11.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Detail
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.1.5 Merck & Co. Inc. Recent Development
11.2 Helsinn Group
11.2.1 Helsinn Group Company Detail
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.2.5 Helsinn Group Recent Development
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Detail
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.4.5 Kyowa Kirin Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.5.5 Sanofi Recent Development
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Detail
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.6.5 Qilu Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Taiji group
11.8.1 Taiji group Company Detail
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.8.5 Taiji group Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.9.5 Novartis Recent Development
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Detail
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.10.5 Heron Therapeutics Recent Development
11.11 Atnahs Pharma UK Limited
11.11.1 Atnahs Pharma UK Limited Company Detail
11.11.2 Atnahs Pharma UK Limited Business Overview
11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction
11.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.11.5 Atnahs Pharma UK Limited Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.12.5 Mylan Recent Development
11.13 Duchesnay
11.13.1 Duchesnay Company Detail
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.13.5 Duchesnay Recent Development
11.14 Tesaro
11.14.1 Tesaro Company Detail
11.14.2 Tesaro Business Overview
11.14.3 Tesaro Nausea And Vomiting Treatment Introduction
11.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.14.5 Tesaro Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 6. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2019-2024)
Table 7. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 8. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2025-2030)
Table 9. Global Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 10. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2019-2024)
Table 11. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 12. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2025-2030)
Table 13. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Nausea And Vomiting Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Nausea And Vomiting Treatment Market Share by Region (2019-2024)
Table 16. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Nausea And Vomiting Treatment Market Share by Region (2025-2030)
Table 18. Nausea And Vomiting Treatment Market Trends
Table 19. Nausea And Vomiting Treatment Market Drivers
Table 20. Nausea And Vomiting Treatment Market Challenges
Table 21. Nausea And Vomiting Treatment Market Restraints
Table 22. Global Top Nausea And Vomiting Treatment Manufacturers by Revenue (US$ Million) & (2019-2024)
Table 23. Global Nausea And Vomiting Treatment Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Nausea And Vomiting Treatment Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 25. Global Key Players of Nausea And Vomiting Treatment, Headquarters and Area Served
Table 26. Global Nausea And Vomiting Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Nausea And Vomiting Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. North America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 32. North America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 33. Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 41. Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 42. Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 43. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Merck & Co. Inc. Company Detail
Table 46. Merck & Co. Inc. Business Overview
Table 47. Merck & Co. Inc. Nausea And Vomiting Treatment Product
Table 48. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 49. Merck & Co. Inc. Recent Development
Table 50. Helsinn Group Company Detail
Table 51. Helsinn Group Business Overview
Table 52. Helsinn Group Nausea And Vomiting Treatment Product
Table 53. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 54. Helsinn Group Recent Development
Table 55. Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
Table 56. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
Table 60. Kyowa Kirin Company Detail
Table 61. Kyowa Kirin Business Overview
Table 62. Kyowa Kirin Nausea And Vomiting Treatment Product
Table 63. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 64. Kyowa Kirin Recent Development
Table 65. Sanofi Company Detail
Table 66. Sanofi Business Overview
Table 67. Sanofi Nausea And Vomiting Treatment Product
Table 68. Sanofi Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. Qilu Pharma Company Detail
Table 71. Qilu Pharma Business Overview
Table 72. Qilu Pharma Nausea And Vomiting Treatment Product
Table 73. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 74. Qilu Pharma Recent Development
Table 75. Teva Pharmaceutical Industries Ltd. Company Detail
Table 76. Teva Pharmaceutical Industries Ltd. Business Overview
Table 77. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
Table 78. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 79. Teva Pharmaceutical Industries Ltd. Recent Development
Table 80. Taiji group Company Detail
Table 81. Taiji group Business Overview
Table 82. Taiji group Nausea And Vomiting Treatment Product
Table 83. Taiji group Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 84. Taiji group Recent Development
Table 85. Novartis Company Detail
Table 86. Novartis Business Overview
Table 87. Novartis Nausea And Vomiting Treatment Product
Table 88. Novartis Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Heron Therapeutics Company Detail
Table 91. Heron Therapeutics Business Overview
Table 92. Heron Therapeutics Nausea And Vomiting Treatment Product
Table 93. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 94. Heron Therapeutics Recent Development
Table 95. Atnahs Pharma UK Limited Company Detail
Table 96. Atnahs Pharma UK Limited Business Overview
Table 97. Atnahs Pharma UK Limited Nausea And Vomiting TreatmentProduct
Table 98. Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 99. Atnahs Pharma UK Limited Recent Development
Table 100. Mylan Company Detail
Table 101. Mylan Business Overview
Table 102. Mylan Nausea And Vomiting TreatmentProduct
Table 103. Mylan Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 104. Mylan Recent Development
Table 105. Duchesnay Company Detail
Table 106. Duchesnay Business Overview
Table 107. Duchesnay Nausea And Vomiting TreatmentProduct
Table 108. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 109. Duchesnay Recent Development
Table 110. Tesaro Company Detail
Table 111. Tesaro Business Overview
Table 112. Tesaro Nausea And Vomiting TreatmentProduct
Table 113. Tesaro Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 114. Tesaro Recent Development
Table 115. Merck & Co. Inc. Company Information
Table 116. Merck & Co. Inc. Business Overview
Table 117. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 118. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 119. Merck & Co. Inc. Recent Development
Table 120. Helsinn Group Company Information
Table 121. Helsinn Group Business Overview
Table 122. Helsinn Group Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 123. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 124. Helsinn Group Recent Development
Table 125. Unimed Pharmaceuticals (AbbVie Inc.) Company Information
Table 126. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
Table 127. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 128. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 129. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
Table 130. Kyowa Kirin Company Information
Table 131. Kyowa Kirin Business Overview
Table 132. Kyowa Kirin Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 133. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 134. Kyowa Kirin Recent Development
Table 135. Sanofi Company Information
Table 136. Sanofi Business Overview
Table 137. Sanofi Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 138. Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 139. Sanofi Recent Development
Table 140. Qilu Pharma Company Information
Table 141. Qilu Pharma Business Overview
Table 142. Qilu Pharma Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 143. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 144. Qilu Pharma Recent Development
Table 145. Teva Pharmaceutical Industries Ltd. Company Information
Table 146. Teva Pharmaceutical Industries Ltd. Business Overview
Table 147. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 148. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 149. Teva Pharmaceutical Industries Ltd. Recent Development
Table 150. Taiji group Company Information
Table 151. Taiji group Business Overview
Table 152. Taiji group Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 153. Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 154. Taiji group Recent Development
Table 155. Novartis Company Information
Table 156. Novartis Business Overview
Table 157. Novartis Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 158. Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 159. Novartis Recent Development
Table 160. Heron Therapeutics Company Information
Table 161. Heron Therapeutics Business Overview
Table 162. Heron Therapeutics Nausea And Vomiting Treatment Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 163. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 164. Heron Therapeutics Recent Development
Table 165. Atnahs Pharma UK Limited Company Information
Table 166. Atnahs Pharma UK Limited Business Overview
Table 167. Atnahs Pharma UK Limited Nausea And Vomiting TreatmentRevenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 168. Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 169. Atnahs Pharma UK Limited Recent Development
Table 170. Mylan Company Information
Table 171. Mylan Business Overview
Table 172. Mylan Nausea And Vomiting TreatmentRevenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 173. Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 174. Mylan Recent Development
Table 175. Duchesnay Company Information
Table 176. Duchesnay Business Overview
Table 177. Duchesnay Nausea And Vomiting TreatmentRevenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 178. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
Table 179. Duchesnay Recent Development
Table 180. Tesaro Company Information
Table 181. Tesaro Business Overview
Table 182. Tesaro Nausea And Vomiting TreatmentRevenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
Table 183. Tesaro Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million) Portfolio
